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One-pot synthesis of novel derivatives of bis-chalcones has been achieved by condensation of 1,4-diacetylbenzene with 
different aldehydes in basic media. The reaction of chalcone derivatives 3a,b with thioglycolic acid gives compounds 4a,b. 
This, when reacted with ethyl cyanoacetate in presence of ammonium acetate gives the corresponding cyanopyridine 
derivatives 5a,b. Furthermore, bis-chalcone 3a,b has been cyclized to pyrazole analogs by using 2,4-dinitrophenylhydrazine 
to give compounds 7a,b in good yields. All products have been characterized by IR, 1H and 13C NMR, and elemental 
analysis. The newly synthesised compounds have been screened for anti-bacterial activity 
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Chalcones, α, β-unsaturated ketones containing of two 
aromatic rings (ring A and B) (Figure 1), are abundant 
in edible plants1. Chalcones have many biological 
activities inclusive of antiviral2-4, antibacterial5,6, 
anti-inflammatory7,8 antifungal9,10, anticancer11, 
antioxidant12, analgesic13, antiulcer14, antimalarial15 and 
antihelmintic16 and thus include a class with important 
therapeutic potential. The Michael addition is a very 
important reaction in organic chemistry because it 
enables the formation of C-C , C-N , C-S , C-O and 
C-P17 bonds. The conjugate addition of thiols to α, 
β-unsaturated carbonyl compounds are recognized thia- 
Michael addition, which is a key reaction for the 
synthesis of β-mercapto carbonyl compounds18,19. 
Those compounds are beneficial intermediates in the 
synthesized of bioactive organosulfur derivatives 
which include thiochromenopyridines20. 
Results and Dissection 
Chalcone derivatives 3a,b21 were synthesized by 
Claisen-Schmidt Condensation. 1,4-diacetyl benzene 
was reacted with substituted benzaldehyade 2a,b in 
presence of 30% sodium hydroxide as catalyst stirring 
at room temperature about 8 hrs to yield bis-chalcone 
derivatives 3a,b in high yields (Scheme I). 
Furthermore, compounds of bis-chalcones 3a,b were 
confirmed by spectral analysis such as IR spectrum of 
compound 3a showed absorption peak at 1654 cm-1 
for (C=O), 3055 cm-1 for an aromatic group and 3b 
appearance peak at 1680 cm-1 for (C=O) and another 
peak at for C=C 1570 cm-1. The IR frequency of 
C=O group is below than the standard value 
(ca. 1700 cm−1) as a result of the conjugation effect 
along with the C=C-C=O moiety. UV spectra 
appearance peak at λ max =460 cm-1. 
Mechanism for synthesized bis-chalcones 
derivatives 3a,b proceed by two steps as shown in 
Figure 2. 
Figure 1 




Enolate ions are formed when molecules with 
hydrogens alpha to a carbonyl group are treated with a 
base like sodium hydroxide. 
Enolate ions are formed when molecules with 
hydrogens alpha to a carbonyl group are treated with a 








The enolate will normally react with unreached 
aldehyde to undergo the "aldol addition" or "aldol 
condensation" 
In otherwise, the addition of thioglycolic acid to 
bis-chalcones derivatives 3a,b with stirring at room 
temperature in presence of 10% iodine dissolved in 
methylene dichloride selectively to afford compounds 
4a,b (Figure 3, Figure 4, Scheme II). Compounds 
4a,b were characterized by IR spectrum showed 
absorption bands at 1720 cm-1for (C=O) of acid,1680 
cm-1(C=O) and (C-S) at 1267 cm-1. 
Thus, the reaction of bis-chalcone derivatives 3a,b 
with ethyl acetoacetate in presence of 10% sodium 
hydroxides under reflux for 2 hrs to give 
 
 
Scheme I — Synthesized of bis-chalcones derivatives 3a,b 
 
 
Figure 2 — Mechanism for synthesized bis-chalcones derivatives 3a,b 




cyclohexanone derivatives 5a,b (by Robinson 
annulations methods). IR spectrum of compound 5a,b 
showed absorption peak at 2218 and 2122 cm-1 for 
(CN) respectively, and another band at 3126 cm-1for 
(NH). The reaction of Chalcone 3a,b with ethyl cyano 
acetate in the presence of ammonium acetate and 
ethanol gave cyanopyridine derivatives 6a,b  
(Scheme III). 
Probable mechanism of formation for synthesized 
compound 6a,b is shown in Figure 5 
Chalcone derivatives 3a,b reacted with 2,4-
dinitrophenylhydrazine in presen ce of a drop of 
glacial acetic acid under reflux for 13 hours yielded 
pyrazolo derivatives 7a,b (Scheme IV). IR spectrum 
of compound 7a,b showed absorption peak at 1352-
1556 cm-1 for (NO2) and absent the absorption peak at 
1680 cm-1 for (C=O). 
 
Results of the antibacterial activity of synthesized 
compounds 
All the tested compounds were active against  
E. coli with variable degrees where NE showed the 
largest inhibition zone (18 mm) while minimum 
activity was recorded against Ps. Aeruginosa 
(inhibition zones 12-13 mm).The compounds had no 
activity against tested gram positive bacterial species 
S. aureus and B .subtilis (Table I, Figure 6). 
 
Experimental Section 
Melting points have been recorded by Electro 
Thermal IA 9 100 series digital melting point 
apparatus contains in capillaries and are not 
corrected. ir spectrum were recorded in the  
solid state as KBr discs using a Perkin-Elmer  
model 1430 spectrometer. 1H NMR spectra have  
been determined on a Varian /Gemini 400 MHz 
spectrometer in DMSO-d6 used AS solvent and TMS 
used as an internal standard. Chemical shifts are 
given in δ (ppm). Mass spectra were measured on an 
instrument VG-7035 at 70 or 15 eV. Elemental 
analyses were determined at the Micro Analytical 
Centre, Cairo University and Giza, Egypt. 
 
1,4-Diacetylbenzene chalcone (3a); N,N-
dimethyl1,4-diacetylbenzene chalcone (3b) 
To a mixture of (0.02 mole) of 1,4-acetyl benzene 
dissolved in solution of (5 ml) 30% sodium hydroxide 
and (15 ml) ethanol. (0.04 mole) of benzaldehyde 
derivatives was added with stirring at room 
temperature for 8 hr. a white-yellowish precipitate 
was obtained, washed with water, and then 
recrystallized from ethylacetate, diethylether. 
3a: Color yellowish; yield 92% % m.p. 193–195oC; 
IR (KOH; cm-1): 3055, 1654, 1573, 1207. Anal. Calcd 
for (C24H18O2; 338.4): C, 85.18; H, 5.36. Found: C, 
85.16; H, 5.38. 
3b: Color orange; yield 86 % m.p. 267-269oC; IR 
(KOH; cm-1): 3026, 2887, 1680. Anal. Calcd for 
(C28H28N2O2; 424.53): C, 79.22; H, 6.65; N, 6.60. 
Found: C, 79.25; H, 6.61; N, 6.63. 
 
1, 4-Bis [2-(1-(4-N,N-dimethylphenyl)-3-oxo-3-













Scheme II — Synthesis of compounds 4a,b 











Figure 5 — Mechanism for synthesised compounds 6a,b 










To a solution of bis-chalcone derivative 3a,b (1 
1mmol) and thioglycollic acid (2mmol) in 
dichloromethane (20ml) was added the solution of 
iodine (10% mole) in dichloromethane (1 mL) and the 
mixture was stirred at room temperature for 5 hours. 
Then, iodine removed with diluted Na2S2O3 solution 
and washed with H2O. The organic layer was dried 
over Na2SO4 and the solvent removed under vacuum. 
The crude product was purified on by crystallized in 
CCl4/n-hexane (1:3). 
4a: IR (KOH; cm-1). 3348, 3028, 2943, 2360, 1720, 
1680, 1594, 1337, 1267, 1227, 1451. 
1HNMR(400MHz, DMSO, δ, ppm): 10.23 (s, 2H, 
2OH); 7.42-7.21(m, 10H, 2Ph); 7.05-7.02 (m, 4H, 
Ph); 4.32(t, J=6.1Hz, 2H); 2.81(d, 4H, 2CH2); 2.53(d, 
4H, 2CH2).
 13C NMR (DMSO-d6) δ: 196.3, 137.4, 
134.2, 128.5, 127.0, 128.9, 127.4, 45.4, 33.1. Anal. 
Calcd for (C28H26O6S2; 522.63). C, 64.35; H, 5.01; S, 
12.27.Found: C, 64.38; H, 5.04; S, 12.25. 
4b: IR (KOH; cm-1): 3421, 3324, 2971, 2885, 2679, 
1712, 1675, 1608, 1573, 1259, 1307, 1239. 1HNMR 
(400MHz, DMSO, δ, ppm): 12.51 (s, 2H, 2OH); 7.92-
7.71(m, 8H, 2Ph); 7.45-7.34 (m, 4H, Ph); 4.52(t, J=6. 
9Hz, 2H); 3.61(d, J=15.2, 4H, 2CH2); 3.12 (d, J=17.1, 
4H, 2CH2), 2.86 (s, 12H, 4CH3). Anal. Calcd for 
(C32H36N2O6S2, 608.77): C, 63.13; H, 5.96; N, 4.60; S, 
10.53.Found: C, 63.10; H, 5.92; N, 4.63; S, 10.56. 
 
1, 4-Bis (1,2,5,6-tetrahydro-2-oxo-4,6-pyridine-
3-carbonitrile ) benzene (5a); 1, 4-Bis (4-(4-
(dimethylamino)phenyl)-1,2,5,6-tetrahydro-2-oxo-
pyridine-3-carbonitrile) benzene (5b) 
Table I — The antibacterial activity of the synthesized 
compounds against tested isolates 
Compd Diameter of inhibition zone (mm) 
S. aureus B. subtilis E. coli P .aeruginosa 
4b − − 14 13 
5b − − 18 12 
6b − − 15 13 
7a − − 16 13 
7b − − 16 12 
 




Chalcone 3a,b (1mmol), ethylacetoacetate (2 
mmol) were dissolved in ethanol (15ml) in presence 
of 10% NaOH(0.5ml). the mixture was refluxed for 
3hr,then cooling at room temperature and the reside 
filtrated m recrystallization from ethanol. 
5a: IR (KOH; cm-1): 3126, 3068, 2953, 1559, 2131 
cm-1. 1HNMR (400MHz, DMSO, δ, ppm): 9.63 (1H, 
NH); 7.36-8.25 (m, 12H, Ar-H); 2.42 (d, J=13.4, 4H, 
2CH2); 3.98 (t, 2H, CH). Anal. Calcd for 
(C30H22N4O2; 470.52): C, 76.58; H, 4.71; N, 11.91. 
Found: C, 76.60; H, 4.77; N, 11.96. 
5b: IR (KOH; cm-1): 3326, 3079, 2953, 2122, 1602. 
1HNMR (400MHz, DMSO, δ, ppm): 10.12 (s, 1H, 
NH); 7.36-8.25 (m, 10H, Ar-H); 2.63 (d, J=13.4, 4H, 
2CH2); 4.13 (t, 2H, CH). Anal. Calcd for: 
(C34H32N6O2; 556.66): C, 73.36; H, 5.79; N, 15.10. 
Found: C, 73.42; H, 5.81; N, 15.14. 
 
1, 4-Bis (ethyl 6(phenyl)-2-oxo-4-cyclohex-3-
enecarboxylate) benzene (6a); 1, 4-Bis (ethyl 6-(4-
N,N-dimethylphenyl)-2-oxo-4-cyclohex-3-
enecarboxylate) benzene (6b) 
Solution of bis- chalcone 3a,b (1mmol) and 
ethylcynao acetate (2mmol) in ethanol (25ml) was 
added to ammonium acetate (4mmol), the reaction 
mixture was heated under reflux for 12 hr. the 
solution cooled and poured into ice water (30 ml). 
The residue was precipitated and filtration, 
recrystallization from ethanol. 
6a: IR (KOH; cm-1): 3386, 3020, 2953, 2839, 1725, 
1652, 1643, 1397, 1248. 1HNMR (DMSO-d6, 400 MHz) 
δ: 1.23(t, 3H, 2CH2-CH3), 6.45 (s,2H, 2C=CH), 6.95-
7.75 (m, 14H, Ar-H) 3.12 (q, 4H, 2COOCH2CH3), 3.86-
3.88 (d, 2H, 2Ha), 3.98 (d, 2H, 2Hb), 3.71-3.72(d, 4H, 
2CH2). 
13C NMR (DMSO-d6) δ:14.3, 26.8, 36.2, 59.6, 
64.8, 127.3, 128.2, 129.5, 138.2, 149.1, 1. 151.6, 172.4, 
196.7. Anal. Calcd for (C36H34O6; 562.65): C, 76.85; H, 
6.09. Found: C, 76.81; H, 6.13. 
6b: IR (KOH; cm-1): 3386, 3020, 2953, 2839, 1725, 
1652, 1643, 1397, 1248. 
1HNMR (DMSO-d6, 400 MHz) δ: 
13C NMR 
(DMSO-d6) δ: 14.2, 26.6, 35. 6, 42.3, 60.6, 63.8, 
128.3, 129.2, 130.1, 139.2, 149.13, 152.6, 173.1, 
193.7. Anal. Calcd for (C40H44N2O6; 648.79): C, 
74.05; H, 6.84; N, 4.32. Found: C, 74.12; H, 6.89; N, 
4.35. 
 
1, 4-Bis [(4-(4,5-dihydro-1-(2,4-dinitrophenyl) 
-5-phenyl-1H-pyrazol-5-yl]) benzene (7a) 1, 4-Bis  
[(4-(4,5-dihydro-1-(2,4-dinitrophenyl)-5-N,N-dimeth 
ylbenzenamine -1H-pyrazol-5-yl]) benzene (7b) 
A mixture of 3a,b (1 mmol) in ethanol (15 ml) and 
2,4-dinitrophenylhydrazine (2mmol) was added with 
(2 drops) glacial acetic acid and the solution was 
refluxed on water bath at 80oC gently for 13 hours. 
After the reaction completed, the solution was 
concentrated and allowed to cool, the product was 
filtered and washed with distilled water, dried and 
recrystallised from ethanol (15 ml). 
7a: IR (KOH; cm-1): 3016, 1559, 1552-1332. 
1HNMR (400MHz, DMSO, δ, ppm): 6.94-7.76(m, 
20H, Ar-H); 3.65 (d, J=15.3, 4H, 2CH2); 3.91 (t, 2H, 
 
 
Figure 6 — The antibacterial activity of synthesized compounds against tested bacterial species: S. aureus (B) B. subtilis (C) E. coli  
(D) P. aeruginosa 




CH). Calcd for (C36H26N8O8; 698.64): C, 61.89; H, 
3.75; N, 16.04. Found: C, 61.92; H, 3.79; N, 16.12. 
7b: IR (KOH; cm-1): 3026, 2981, 1445, 1602, 
1352-1556. 1HNMR (400MHz, DMSO, δ, ppm): 
6.89-7.92 (m, 18H, Ar-H); 3.46 (d, J=14.32, 4H, 
2CH2); 3.86 (t, 2H, CH); 1.29 (s, 12H, 4CH3). 
13C 
NMR (DMSO-d6) δ: 152.8, 145.5, 138.2, 134.2, 
128.5, 127.0, 128.9, 127.4, 53.5, 40.4. Anal. Calcd for 
(C40H36N10O8; 784.78 ): C, 61.22; H, 4.62; N, 17.85. 
Found: C, 61.39; H, 4.68; N, 17.80. 
 
Screening of the antibacterial activity of 
synthesized compounds 
(i) Test microorganisms 
The bacterial isolates used in this test were 
supplied by Microbiology and Immunology lab, 
Faculty of pharmacy, Mansoura university. The 
selected species were S. aureus, B. subtilis, E. coli 
and Ps. aeruginosa.The isolates were grown 
overnight in a rotary shaker at 37°C then adjusted to a 
concentration of 108 cells/ml using 0.5 McFarland 
standard. 
 
(ii) Screening of the antibacterial activity 
Agar well diffusion method22 was used to evaluate 
the antibacterial activity of the synthesized compounds. 
Thirty micro liters of each readjusted bacterial culture 
was inoculated into 15 ml of Muller Hinton agar, 
mixed well and poured into 10 mm Petri dish. Using a 
sterile Wassermann tube, wells were made in the 
seeded agar plates and 50 µl of each compound (500 
mg) were added to the corresponding wells. Then, 
plates were incubated at 37°C for 18 h. Cloxacillin and 
tobramycin were used as reference antimicrobials. 
Dimethyl formamide (solvent) was used as negative 
control. Results were recorded by measuring the 
diameter of growth inhibition zone (in mm). 
 
Conclusions 
Some new of heterocyclic compounds derivatives 
have been synthesized from 1,4-diacetylbenzene 
derivatives. Chemical properties of these compounds 
were studied, and some of these compounds showed 
potential antimicrobial activity. 
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